DMVF3.SA d1000 Varejo Farma Participações S.A
- Market cap
- BRL 231M
- P/E
- 11.1x
- P/B
- 0.24x
- ROE
- 0.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.
Is DMVF3.SA undervalued?
Graham numberDMVF3.SA trades 65.6% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
d1000 Varejo Farma Participações S.A fundamental analysis
No fundamental analysis for d1000 Varejo Farma Participações S.A yet.
d1000 Varejo Farma Participações S.A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About d1000 Varejo Farma Participações S.A
d1000 Varejo Farma Participações S.A. engages in the retail sale of pharmaceutical and perfumery products in Brazil. It sells generic drugs, OTC, and personal care and beauty products. The company was formerly known as Cancun RJ Participações S/A and changed its name to d1000 Varejo Farma Participações S.A. in March 2016. The company was incorporated in 2010 and is headquartered in Rio De Janeiro, Brazil. d1000 Varejo Farma Participações S.A. is a subsidiary of Profarma Dist…
Full company profiled1000 Varejo Farma Participações S.A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
d1000 Varejo Farma Participações S.A annual financial statements (BRL; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 1.14B | 1.16B | 1.13B | 1.00B | 1.14B | 1.48B | 1.75B | 2.16B | 2.67B | 2.64B |
| Gross Profit | 369M | 347M | 342M | 325M | 371M | 476M | 553M | 662M | 762M | 808M |
| Operating Income | -39.0M | 9.55M | -20.9M | 6.65M | -2.11M | 35.6M | 51.3M | 63.2M | 83.9M | 1.75M |
| EBITDA | -14.6M | 33.4M | 150M | 90.7M | 99.3M | 140M | 160M | 181M | 210M | 144M |
| Net Income | -72.3M | 2.68M | -7.49M | 123K | 1.98M | 11.4M | 21.4M | 25.9M | 22.6M | 6.06M |
| EPS | -1.43 | 0.05 | -0.15 | 0.00 | 0.04 | 0.22 | 0.42 | 0.51 | 0.45 | 0.12 |
| Balance Sheet | ||||||||||
| Total Assets | 1.01B | 1.01B | 1.10B | 1.45B | 1.47B | 1.47B | 1.55B | 1.83B | 1.95B | 1.98B |
| Total Liabilities | 749M | 523M | 630M | 619M | 632M | 621M | 678M | 938M | 1.03B | 1.06B |
| Shareholders' Equity | 257M | 492M | 466M | 836M | 838M | 849M | 871M | 897M | 919M | 921M |
| Cash & Short-term Investments | 46.7M | 57.6M | 49.2M | 206M | 96.4M | 56.5M | 44.2M | 57.6M | 45.9M | 23.0M |
| Total Debt | 19.4M | 87.4M | 205M | 215M | - | - | - | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | -110M | -35.9M | 61.7M | 5.80M | 95.0M | 103M | 146M | 177M | 165M | 115M |
| Capital Expenditure | 3.37M | 14.8M | 20.2M | 32.7M | 48.9M | 34.3M | 58.0M | 94.8M | 92.4M | 78.7M |
| Free Cash Flow | -124M | -50.7M | 41.5M | -26.9M | 38.7M | 62.5M | 88.0M | 81.9M | 72.8M | 35.9M |
| Ratios | ||||||||||
| ROE | -28.1% | 0.5% | -1.6% | 0.0% | 0.2% | 1.3% | 2.5% | 2.9% | 2.5% | 0.7% |
| ROA | -7.2% | 0.3% | -0.7% | 0.0% | 0.1% | 0.8% | 1.4% | 1.4% | 1.2% | 0.3% |
| Net Profit Margin | -6.3% | 0.2% | -0.7% | 0.0% | 0.2% | 0.8% | 1.2% | 1.2% | 0.8% | 0.2% |
| Debt to Equity | 0.08x | 0.18x | 0.44x | 0.26x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
d1000 Varejo Farma Participações S.A dividends
d1000 Varejo Farma Participações S.A has not paid dividends in the last 9 fiscal years.
Who owns d1000 Varejo Farma Participações S.A
- Insiders 73.78%
- Institutions 8.74%
- Public & others 17.48%
- Shares outstanding 50.6M
- Free float 9.55M
d1000 Varejo Farma Participações S.A company profile
- Company name
- d1000 Varejo Farma Participações S.A
- Ticker
- DMVF3.SA
- ISIN
- BRDMVFACNOR9
- Exchange
- Sao Paulo Exchange
- Sector
- Healthcare
- Industry
- Consumer Staples Distribution & Retail
- Employees
- 4,500
- Fiscal year end
- December
- Address
- CasaShopping, Rio De Janeiro, RJ, Brazil, 22775 056
- Phone
- 55 21 2253 5252
- Website
- d1000varejofarma.com.br/ri
About d1000 Varejo Farma Participações S.A
d1000 Varejo Farma Participações S.A. engages in the retail sale of pharmaceutical and perfumery products in Brazil. It sells generic drugs, OTC, and personal care and beauty products. The company was formerly known as Cancun RJ Participações S/A and changed its name to d1000 Varejo Farma Participações S.A. in March 2016. The company was incorporated in 2010 and is headquartered in Rio De Janeiro, Brazil. d1000 Varejo Farma Participações S.A. is a subsidiary of Profarma Distribuidora de Produtos Farmacêuticos S.A.
d1000 Varejo Farma Participações S.A management
4- Mr. Sammy BirmarckerCEO, Chairman of Executive Board & Director
- Marcelo CardosoVice Chairman of Executive Board
- Rita Cristiane Ribeiro CarvalhoFinancial & Investor Relations Director and Member of Executive Board
- Livio Barboza SilvaDirector of Operations & Member of Executive Board